Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**IGBP1 pseudogene 1 (IGBP1P1)** is classified as a pseudogene—an inactive DNA sequence similar to the functional IGBP1 gene but generally considered non-coding and not expressed as a functional protein in humans. Pseudogenes have traditionally been thought to lack biological activity, though some may have regulatory roles at the RNA level; however, there are no documented roles, functions, or disease associations specifically for IGBP1P1. It is not regarded as a therapeutic target and does not have relevant interactions with drugs or established safety considerations[7][8]. **Key points:** - **IGBP1P1 is a pseudogene, not a protein-coding gene**[7]. - It does not encode a protein and is not a recognized therapeutic target. - There is no evidence of biological or pathological function or use as a biomarker for IGBP1P1 specifically. - Information about drugs, mechanisms of action, and safety is not applicable. **Clarification:** If you meant the active gene **IGBP1 (Immunoglobulin-binding protein 1)**: - It is a protein-coding gene involved in B-cell receptor signaling, has some documented disease associations and biomarker relevance (notably in lupus nephritis), and may be a drug target candidate in signaling/modulatory pathways[1][2][3]. - *IGBP1P1*, as a **pseudogene**, should not be confused with the active IGBP1 gene. **Summary:** IGBP1P1 is a non-protein-coding pseudogene, **not suitable** as a drug target or biomarker, and information about its biology or pharmacology is not applicable[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IGBP1 pseudogene 1 (IGBP1P1).